Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

This page is alzhub.org's plain-English summary of a published study, not the paper itself. It is generated from the record we hold for this study, sourced and linked below — check the original for the full text and methods.

✓ Peer-reviewed alzhub usefulness score 57 out of 100. Risk genes beyond APOE

Topic: Risk, prevention and care in population studies

UNDERLYING BIOLOGICAL MECHANISMS PNDs result from a complex interplay of multiple biological, genetic, and environmental factors (Table 1). Estrogen supports BBB function by upregulating tight junction proteins (claudin-5, occludin), enhancing nitric oxide–mediated vasodilation, and promoting angiogenesis via vascular endothelial growth factor (VEGF) signaling.11–13 Premenopausal women have higher cerebral blood flow than men, which may confer resilience against ischemic and inflammatory insults.11 These neurovascular benefits decrease with menopause: declining estrogen levels are associated with increased BBB permeability, decreased microglial regulation, and heightened neuroinflammatory responses, contributing to greater risk of PND in postmenopausal women.5,11,19 Testosterone also influences BBB integrity in a dose-dependent manner: physiological levels support vascular stability and dampen inflammation, whereas low levels increase permeability and cytokine release, and excessive levels promote vascular inflammation and thrombosis.5,6,13 Neuroinflammatory Cascades Sexual dimorphism is observed in baseline immune profiles. When sex is examined, results are frequently inconsistent or null, often in the context of limited total sample size, marked sex imbalance, or insufficient power to detect sex-by-context interactions. In a 2023 systematic review of 165 studies, only 29 reported sex as a variable in relation to POD, and just five identified sex as a significant risk factor (three female, two male).1 Notably, no pooled meta-analysis of sex effects was performed, underscoring the fragmented nature of the evidence. Cardiac surgery studies yield conflicting results, with some reporting higher POD risk among men26 and others reporting substantially higher risk among women in pooled analyses of randomized trials.27 Orthopedic surgery studies more consistently identify male sex as a risk factor for POD,25,28,30 though these associations often attenuate after adjustment for comorbidities and age. These findings in two different patient populations highlight the ambiguity surrounding the role of sex in perioperative brain health outcomes. Table 2. - Summary of Sex-Based Differences in Perioperative Delirium and Neurocognitive Disorder Outcomes Across Clinical Studies Study—setting Population Sex-based findings Comments Systematic review1 165 studies included: Adults >18 yNoncardiac and non-neurologic surgeries -29 of 165 studies reported data on sex association

Cite this study APA, Vancouver, BibTeX · download .bib or .ris

APA 7th

Seyour, M., Berger‐Estilita, J., Gisselbaek, M., Rubulotta, F., & Saxena, S. (2026). Sex-Based Differences in Perioperative Brain Health Outcomes. A&A Practice. https://doi.org/10.1213/xaa.0000000000002200

Vancouver

Seyour M, Berger‐Estilita J, Gisselbaek M, Rubulotta F, Saxena S. Sex-Based Differences in Perioperative Brain Health Outcomes. A&A Practice. 2026. doi:10.1213/xaa.0000000000002200. PMID: 42139451.

BibTeX

@article{seyour2026-42139451,
  author  = {Seyour, Mohamed and Berger‐Estilita, Joana and Gisselbaek, Mia and Rubulotta, Francesca and Saxena, Sarah},
  title   = {{Sex-Based Differences in Perioperative Brain Health Outcomes}},
  journal = {A\&A Practice},
  year    = {2026},
  doi     = {10.1213/xaa.0000000000002200},
  pmid    = {42139451},
  url     = {https://doi.org/10.1213/xaa.0000000000002200}
}

Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.

Key findings

Why it matters

This review discusses sex-based differences in perioperative brain health outcomes and notes that when sex is examined, results are frequently inconsistent or null. It does not test or demonstrate any treatment, cure or prevention for Alzheimer's disease.

Study details

How this study scored 57/100
How this study's score is builtJournal tier 7 of 10; Journal's citation record 0 of 4; Study design 12 of 12; Strength of evidence 5 of 5; Peer-review validation 10 of 10; How recent 5 of 5; Sample size 3 of 4; Effect reported 3 of 3; Studied in people 3 of 3; Randomised / blinded 0 of 2; Times cited 0 of 7; Citations per year 0 of 5; Impact for its field and year 0 of 6; Cited by studies here 0 of 6; Still being cited 0 of 4; Senior author's track record 1 of 4; Institution's track record 1 of 3; Multi-centre collaboration 3 of 3; Indexed in PubMed 2 of 2; Free to read 2 of 2. Total 57 of 100.57 of 100 points earned43 not earned

Published in a peer-reviewed journal, and it is a systematic review of all the studies on the question.

ComponentPointsWhy
Journal tier 7 / 10 Tier 3 — peer-reviewed journal (A&A Practice)
Journal's citation record 0 / 4 A&A Practice: journal h-index 24 (OpenAlex, 2026-10-29)
Study design 12 / 12 A systematic review of all the studies on the question
Strength of evidence 5 / 5 Rated “high” in our summary
Peer-review validation 10 / 10 Peer-reviewed. Published as an article in a named peer-reviewed journal.
How recent 5 / 5 2026 — within 1 year(s) of the newest study here
Sample size 3 / 4 7,900 participants
Effect reported 3 / 3 Effect reported with a statistic (interval, p-value, ratio or similar)
Studied in people 3 / 3 Studied in people (participant count stated)
Randomised / blinded 0 / 2 A review of other studies — randomisation is not credited here
Times cited 0 / 7 Cited 0 times (OpenAlex, 2026-10-10)
Citations per year 0 / 5 0.0 citations a year over 2 year(s) since 2026
Impact for its field and year 0 / 6 Cited 0.0× the average for papers of its field and year (OpenAlex FWCI)
Cited by studies here 0 / 6 No other study in this library cites it
Still being cited 0 / 4 Cited 0 times in 2024–2026 (2026 still in progress; OpenAlex)
Senior author's track record 1 / 4 Last-listed author Sarah Saxena: h-index 15 (OpenAlex, whole career)
Institution's track record 1 / 3 McGill University: institution h-index 1,373 (OpenAlex)
Multi-centre collaboration 3 / 3 OpenAlex lists 12 institution(s) in 5 countries
Indexed in PubMed 2 / 2 Indexed in PubMed (PMID 42139451)
Free to read 2 / 2 Free to read
Total 57 / 100 —

What each of these 20 components measures, and what this score is not →

Read the original

Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).

Related studies in Risk genes beyond APOE

Also in Risk genes beyond APOE

98 studies in the library are filed under Risk genes beyond APOE with no topic tag they share with another; these are this study's neighbours in a fixed tour of them. The Risk genes beyond APOE hub.

Similar studies

More on Risk genes beyond APOE

See all studies in Risk genes beyond APOE →